2024 biotech deals tracker: the latest partnerships and M&A …cash, and the lead asset acquired is a monoclonal antibody for inflammatory bowel disease. July 2024: Sionna Therapeutics, based in the United States, has partnered with AbbVie, also a U.S…. March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2017 What’s the Gold Standard for Therapeutic Antibodies? …A full 75% of the new generation of mAb drugs is human, and the remainder are humanized – no chimeric or rodent antibodies are currently in the pipeline. Humanized mAbs… March 22, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? …another monoclonal antibody, which snagged the FDA stamp of approval in 2023. LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody that targets amyloid-beta to clear them out of… February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic …is a monoclonal antibody that works by binding to TIGIT, which could activate the immune system to attack cancer cells. Typically, a fragment crystallizable (Fc) region in a monoclonal antibody,… May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 11 Dec 2017 New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech ADC Therapeutics is one of our top biotechs of the year after it brought… December 11, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 15 May 2017 Meet the CEO developing the Next Generation of Antibody Therapeutics Crescendo Biologics has positioned itself as the successor of Cambridge Antibody Technology and a new rival to Morphosys. We interviewed CEO Peter Pack. Peter Pack started working in life science… May 15, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2022 Scancell signs agreement with Genmab …on products sold. The Scancell anti-glycan monoclonal antibody is a humanized antibody developed by Scancell, using its novel anti-cancer GlyMab platform. This is one of five monoclonal antibodies currently in… October 26, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2016 This Technology could Open Up a new 4th Generation of Therapeutic Antibodies …of all therapeutic antibody generations (those with the antibody icon are available at BIOTEM) So how are optimal 4th-gen antibodies developed? 1. Low immunogenicity A foreign antibody can induce an… November 1, 2016 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 8 Jun 2017 Cambridge Antibody Technology: The History of the UK’s Best Biotech …1989. The company, Cambridge Antibody Technology (CAT), would go on to be the biggest success story in UK biotech after its team discovered the blockbuster therapeutic antibody, Humira, and became… June 8, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2022 Transcenta monoclonal antibody gets FDA clearance Transcenta Holding Limited says its TST004 humanized monoclonal antibody targeting MASP2, has received IND clearance from the U.S. Food and Drug Administration (FDA). MASP2, mannose-binding protein-associated serine protease 2, is… October 5, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2017 One Mouse with All-Human Antibodies …a small fraction of this antibody diversity. Then, in 2010, a group of scientists started working on a mouse line that could produce any human antibody in the human antibody… November 29, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2022 Roche launches next-generation SARS-CoV-2 Rapid Antibody Test Roche has launched the SARS-CoV-2 Rapid Antibody Test 2.0 in markets accepting the CE Mark. The test is the next generation of Roche’s existing SARS-CoV-2 Rapid Antibody Test, which launched… October 3, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email